| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |